A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
Condition(s):Secondary HyperparathyroidismLast Updated:November 14, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Secondary HyperparathyroidismLast Updated:November 14, 2018Completed
Condition(s):Primary HyperparathyroidismLast Updated:January 10, 2020Unknown status
Condition(s):Primary HyperparathyroidismLast Updated:October 12, 2021Recruiting
Condition(s):Secondary HyperparathyroidismLast Updated:February 2, 2022Not yet recruiting
Condition(s):Secondary Hyperparathyroidism;ParathyroidectomyLast Updated:September 27, 2021Recruiting
Condition(s):Primary Hyperparathyroidism; OsteoporosisLast Updated:November 9, 2020Enrolling by invitation
Condition(s):Renal Transplant; Secondary HyperparathyroidismLast Updated:February 22, 2013Completed
Condition(s):Primary HyperparathyroidismLast Updated:April 14, 2022Completed
Condition(s):Primary HyperparathyroidismLast Updated:December 13, 2018Completed
Condition(s):Hyperparathyroidism; Parathyroid AdenomaLast Updated:September 30, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.